Observational studyBMC neurology2017

Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.

Anat Achiron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.